Chemotherapy With DNA Damaging Agents In Colorectal Cancer
NCT01456923 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2011-10-21
Summary
Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.
Conditions
Interventions
- OTHER
-
Treatment with chemotherapy
- OTHER
-
Only chemotherapy treatment for study cohort
Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy
- PROCEDURE
-
surgery
Sponsors & Collaborators
-
Centro Hospitalar Nordeste
lead OTHER
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 40 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Comprehensive Management of Rectal Cancer
NCT06839508 ·Status: COMPLETED
-
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
NCT05322486 ·Status: UNKNOWN
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety
NCT01465451 ·Status: UNKNOWN ·Phase: PHASE3
-
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
NCT00682786 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Interest Chemo-oncogramme in Patients With Colonic Adenocarcinoma Stage 4
NCT02305368 ·Status: COMPLETED
-
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
NCT03038217 ·Status: UNKNOWN ·Phase: PHASE3
-
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
NCT01923987 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer
NCT06879197 ·Status: COMPLETED
-
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
NCT00414232 ·Status: COMPLETED
-
Effect of the Use of Symbiotics in Patients With Colon Cancer
NCT04874883 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
NCT01043172 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
NCT04326296 ·Status: UNKNOWN ·Phase: PHASE1
-
Treatment Strategies for Primarily Generalized Colorectal Cancer
NCT01056809 ·Status: TERMINATED ·Phase: NA
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Continuing Care Needs in Colorectal Cancer Patients in Different Stages
NCT00961129 ·Status: UNKNOWN
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NCT06637215 ·Status: RECRUITING ·Phase: NA
-
A Translational Study for Locoregional Recurrence of T4 Colon Cancer
NCT06958926 ·Status: RECRUITING
-
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer
NCT03923309 ·Status: COMPLETED
-
Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
NCT00506623 ·Status: UNKNOWN ·Phase: PHASE2
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases
NCT01307878 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
NCT06024356 ·Status: UNKNOWN